Filing Flows › Amarin (AMRN) › Q2 2026 › vs Q1 2026
Amarin (AMRN) Q2 2026 vs Q1 2026 (quarter over quarter)
Amarin's revenue fell $2.9M (-6%) from $45.1M in Q1 2026 to $42.2M in Q2 2026. The biggest changes: Product −$4.2M (-10%); Licensing and Royalty +$1.3M (+74%).
Amarin, Q2 2026: revenue $42.2M (-42% year over year), operating margin -28.5%, net loss $7.7M, operating cash flow $6.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product | $39.1M | $43.3M | −$4.2M | -10% |
| Licensing and Royalty | $3.1M | $1.8M | $1.3M | +74% |
| Revenue | $42.2M | $45.1M | −$2.9M | -6% |
| Other income, net | $4.1M | $2.6M | $1.5M | +59% |
| Income tax benefit | $219K | −$1.8M | $2.0M | — |
| Net loss | $7.7M | $10.5M | −$2.9M | -27% |
| Costs & expenses | $54.2M | $58.3M | −$4.0M | -7% |
| Operating costs | $54.2M | $56.5M | −$2.2M | -4% |
| Cost of revenue | $27.2M | $27.4M | −$141K | -0.5% |
| Research & development | $4.8M | $4.7M | $108K | +2% |
| SG&A | $22.2M | $21.1M | $1.1M | +5% |
| Operating cash sources | $14.3M | $16.9M | −$2.6M | -16% |
| Share-based compensation | $2.1M | $2.3M | −$231K | -10% |
| Working capital & other | $12.2M | $14.6M | −$2.4M | -17% |
| Net loss absorbed | $7.7M | $10.5M | −$2.9M | -27% |
| Operating cash flow | $6.6M | $6.4M | $216K | +3% |
Questions
How much did Amarin's revenue grow quarter over quarter in Q2 2026?
Amarin's revenue fell $2.9M (-6%) from $45.1M in Q1 2026 to $42.2M in Q2 2026.
What drove Amarin's revenue change in Q2 2026?
Product −$4.2M (-10%); Licensing and Royalty +$1.3M (+74%).